Renal Transplant Results of the Organ Transplant Center of Meram Medical School Between 2003-2011

Basit Öğe Kaydı
dc.contributor.authorTurkmen, Kultigin
dc.contributor.authorFatih, M. Ehmet Erdu R.
dc.contributor.authorErikoglu, Mehmet
dc.contributor.authorGaipov, Abduzhappar
dc.contributor.authorColak, Bayram
dc.contributor.authorTekin, Ahmet
dc.contributor.authorYeksan, Mehdi
dc.date.accessioned2024-02-23T14:41:25Z
dc.date.available2024-02-23T14:41:25Z
dc.date.issued2013
dc.departmentNEÜen_US
dc.description.abstractBJECTIVE: Renal transplantation (RTx) is the best therapeutic modality for end-stage renal disease patients. We report 8 years single-centre experience on cadaveric and living donor RTx in terms of demographic features along with graft functions, posttransplant medical complications, patients-graft survivals. MATERIAL and METHODS: We enrolled 66 RTx (female/male: 36/30) patients including 40 cadaveric and 26 living donors. At admission age, gender, causes of renal failure, dialysis typeduration, type of RTx, induction and maintenance immunosuppressive modalities, rejection episodes, biochemistry-hemogram parameters at 1, 6, 12, 24 and 60 months after transplantation and medical complications were obtained from the medical records. RESULTS: Mean recipient age was 41 +/- 11.6 years. Mean transplant duration was 32.2 +/- 31.4 months, and the mean creatinine values was 1.4 +/- 0.9 mg/dl. The most commonly used immunosuppressive protocol was corticosteroid+tacrolimus+mycophenolate mofetil. Delayed graft function, chronic allograft nephropathy and acute rejection were observed in 27.3%, 25.7% and 13.6% of patients, respectively. 1-and 5-year patient survival rates were 100% and 100% for living donor patients and 85% and 85% for cadaveric patients, respectively. 1- and 5-year graft survival rates were 100% and 100% for living donor RTx patients, and 80% and 80% for cadaveric RTx patients, respectively. The most common medical complications were new onset diabetes mellitus and dyslipidemia. The most common early and late infection was urinary tract infection. CONCLUSION: RTx is the best renal replacement therapy in terms of patient-graft survival. However, patients should be closely moniterized for metabolic complications.en_US
dc.identifier.doi10.5262/tndt.2013.1001.05
dc.identifier.endpage44en_US
dc.identifier.issn1300-7718
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84873602902en_US
dc.identifier.startpage34en_US
dc.identifier.urihttps://doi.org/10.5262/tndt.2013.1001.05
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16844
dc.identifier.volume22en_US
dc.identifier.wosWOS:000217180500005en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherTurk Nefroloji Diyaliz Transplantasyon Dergisien_US
dc.relation.ispartofTurkish Nephrology Dialysis And Transplantation Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEnd Stage Renal Diseaseen_US
dc.subjectHemodialysisen_US
dc.subjectPeritoneal Dialysisen_US
dc.subjectRenal Transplantationen_US
dc.titleRenal Transplant Results of the Organ Transplant Center of Meram Medical School Between 2003-2011en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu